- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID D9673R00025_DESTINY
Trial Description
DESTINY BREAST – RESPOND A multi-center, multi-country prospective observational study of patients initiating T-DXd in the first or second treatment line for HER2+, and HER2-low unresectable and/or metastatic breast cancer
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724
Investigator
- Carol Tweed, M.D.
Disease Types
Sponsor
- AstraZeneca
ClinicalTrials.gov NCT ID
- NCT05592483